Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR2V2 Inhibitors

OR2V2 inhibitors are chemicals that can interfere with the function of the olfactory receptor 2V2, a protein that belongs to the family of G-protein-coupled receptors (GPCRs). GPCRs, such as OR2V2, are integral to the process of signal transduction across cell membranes, translating extracellular cues into cellular responses. OR2V2, specifically, is part of the olfactory system and is involved in the detection of odorants, although the full range of its ligands and the specifics of its role remain less characterized than other GPCRs that have been more intensively studied due to their direct relevance to human diseases. The OR2V2 protein activates intracellular signaling pathways upon binding with an odorant molecule, which leads to a cascade of cellular events resulting in the perception of smell. Inhibition of OR2V2, as with other GPCRs, can occur through various mechanisms. Direct inhibitors would typically bind to the receptor itself, blocking the interaction with its natural ligands. However, since such direct inhibitors for OR2V2 are not widely reported, one can consider indirect inhibition via interference with the downstream signaling components. This includes targeting G proteins that couple with OR2V2 to initiate intracellular responses, phosphodiesterases that modulate the levels of cyclic nucleotides, or kinase pathways that further propagate the signal initiated by OR2V2 activation. Each point in this cascade represents a potential target for inhibition. For example, compounds that modulate the G-protein signaling can alter the receptor's ability to produce second messengers, such as cyclic AMP, thus affecting the receptor's ability to communicate within the cell. Similarly, chemicals that inhibit the action of kinases can affect the phosphorylation state of downstream proteins, thereby modifying the outcome of receptor activation. The complexity of these pathways allows for multiple points of intervention, each with the capability to modulate the signaling of OR2V2 indirectly. The study of these inhibitors contributes to a broader understanding of GPCR regulation, signal transduction, and the nuanced control of sensory perception at the molecular level.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Propranolol is a non-selective beta-adrenergic receptor antagonist that can suppress GPCR-mediated signaling, potentially impacting OR2V2 activity.

Yohimbine hydrochloride

65-19-0sc-204412
sc-204412A
sc-204412B
1 g
5 g
25 g
$50.00
$168.00
$520.00
2
(1)

Yohimbine is an alpha-2 adrenergic receptor antagonist that can inhibit G-protein signaling, which may alter OR2V2's signaling cascade.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$442.00
3
(1)

Pertussis Toxin (islet-activating protein) inactivates Gi/o proteins, thereby impeding GPCR-mediated inhibition of adenylyl cyclase, potentially influencing OR2V2 signaling indirectly.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$199.00
$460.00
$1479.00
1
(0)

NF449 is a potent and selective inhibitor of Gs alpha subunit, which could impair OR2V2-related Gs-mediated signaling pathways.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$103.00
$293.00
$465.00
15
(1)

Go 6983 is a protein kinase C inhibitor, possibly altering GPCR downstream signaling and affecting OR2V2 indirectly.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$97.00
$144.00
$648.00
47
(2)

KT 5720 is a selective inhibitor of protein kinase A, which might modulate OR2V2-related signaling by altering cAMP-dependent pathways.

Clozapine

5786-21-0sc-200402
sc-200402A
50 mg
500 mg
$68.00
$357.00
11
(1)

Clozapine is an antagonist of multiple neurotransmitter receptors, and its broad action on GPCR signaling could extend to modulation of OR2V2 pathways.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY 294002 is a PI3K inhibitor, potentially affecting GPCR-related signaling cascades that could include OR2V2.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Genistein is a tyrosine kinase inhibitor and might influence GPCR signaling by modifying receptor phosphorylation states, thereby impacting OR2V2 function.